Edelgard Anna Kaiser

This inventor holds 8 USPTO granted patents, plus 1 CIPO patent and 5 EPO patents. Top assignee: Roche Diagnostics Operations, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edelgard Anna Kaiser. Retrieved from https://idiyas.com/inventor/edelgard-anna-kaiser

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)

Location History:

Hünenberg See, CH (2020)
Huennenberg See, CH (2022)
Huenenberg See, CH (2019 - 2024)

Company Filing History:

8 out of 1,698

Roche Diagnostics Operations, Inc.

patents

Years Active: 2019-2026

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12517139 - Biomarkers for risk prediction of mortality (2026-01-06),

2. 11874282 - IGFBP-7 as a marker of preeclampsia (2024-01-16),

3. 11644472 - Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation (2023-05-09),

4. 11397187 - IGFBP7 for prediction of risk of AKI when measured prior to surgery (2022-07-26),

5. 11047866 - IGFBP7 for diagnosing diastolic dysfunction (2021-06-29),

6. 10557858 - Biomarkers for risk prediction of mortality (2020-02-11),

7. 10345315 - IGFBP7 for diagnosing diastolic dysfunction (2019-07-09),

8. 10231639 - Algorithm of NTproBNP and hand held ECG to detect arrhythmia in an elderly population (2019-03-19),

Title: Innovations and Contributions of Edelgard Anna Kaiser

Introduction

Edelgard Anna Kaiser is a notable inventor based in Huennenberg See, Switzerland. She has made significant contributions to the field of medical diagnostics, holding a total of 8 patents. Her work focuses on biomarkers that aid in the diagnosis and monitoring of various health conditions.

Latest Patents

One of her latest patents is titled "IGFBP-7 as a marker of preeclampsia." This patent describes a method for diagnosing preeclampsia or related conditions in pregnant subjects by measuring the biomarker IGFBP-7. The method involves comparing the measured amount to a reference, allowing for the assessment of the severity of preeclampsia. Additionally, it includes the use of IGFBP-7 for monitoring these conditions. Another significant patent is "Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation." This patent outlines a method for predicting the risk of atrial fibrillation recurrence by measuring Ang-2 levels in a subject's sample.

Career Highlights

Edelgard Anna Kaiser is currently employed at Roche Diagnostics Operations, Inc., where she continues to innovate in the field of diagnostics. Her work has been instrumental in developing methods that enhance patient care and improve diagnostic accuracy.

Collaborations

Throughout her career, she has collaborated with esteemed colleagues, including Ursula-Henrike Wienhues-Thelen and Dirk Block. These collaborations have further enriched her research and contributions to the field.

Conclusion

Edelgard Anna Kaiser exemplifies the spirit of innovation in medical diagnostics through her patents and contributions. Her work not only advances scientific knowledge but also has the potential to significantly impact patient outcomes.

Profile summary based on public USPTO records.